Skip to content
Sildalist
Active ingredient: Sildenafil, Tadalafil

Sildalist

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Select pack Package Per unit Price

Free delivery on orders from $ 312.00, free express delivery from $ 468.00

Secure Payments
Track your order
Best price guarantee

Sildalist is supplied as tablets for adult men seeking treatment for erectile dysfunction. Its clinical use relates to PDE5-inhibitor therapy, which supports penile blood flow during sexual stimulation.

Overview

PDE5 inhibitors are prescription medicines that enhance the natural nitric-oxide pathway involved in erection. Sildenafil Citrate and Tadalafil are two recognised PDE5-inhibitor substances used in erectile-dysfunction treatment, but their individual dosing, duration, metabolism, and interaction profiles differ.

Dosage and administration

There is no single dose that suits every Sildalist strength or every user. The correct dose depends on the prescribed formulation and the person’s cardiovascular risk, other medicines, kidney function, liver function, and response.

General administration principles for a PDE5-inhibitor tablet include:

  • Take only the prescribed amount.
  • Use no more than one PDE5-inhibitor dose within 24 hours unless a prescriber gives a different written plan.
  • Swallow the tablet with water.
  • Take it before planned sexual activity according to the prescribed timing.
  • Do not combine it with sildenafil, tadalafil, vardenafil, avanafil, or another erectile-dysfunction medicine.
  • Do not increase the dose after a disappointing first response.
  • If a dose is missed, do not double the next dose.

The tablet should not be used as a daily medicine unless the specific formulation and dosing schedule have been prescribed for daily treatment. A high-strength combination tablet is unsuitable for informal dose adjustment.

If too much has been taken, contact emergency services or a poison information service promptly, especially when dizziness, fainting, chest discomfort, or a prolonged erection develops.

Heavy meals can delay the onset of sildenafil-containing treatment. A lighter meal may make timing more predictable, while tadalafil is less affected by food in standard use.

Do not split a high-potency tablet to create an assumed dose. Unless the tablet has been specifically designed and authorised for splitting, the resulting portions may not contain equal amounts of active substance.

Formulation

PDE5 inhibitors are prescription medicines that enhance the natural nitric-oxide pathway involved in erection. Sildenafil Citrate and Tadalafil are two recognised PDE5-inhibitor substances used in erectile-dysfunction treatment, but their individual dosing, duration, metabolism, and interaction profiles differ.

A pharmacist would not assume that two PDE5 inhibitors can be combined safely simply because each one is used for erectile dysfunction. Combining or duplicating PDE5 activity may increase vasodilation, headache, dizziness, visual symptoms, and blood-pressure reduction.

Do not combine Sildalist with another erectile-dysfunction tablet unless the prescriber has specifically confirmed the combination and timing.

Role of active pharmaceutical ingredients

Sildenafil belongs to the PDE5-inhibitor class. Tadalafil belongs to the same pharmacological class but has a longer clinical activity window than sildenafil in standard single-ingredient treatment. Both substances depend on sexual stimulation; neither should produce an erection without arousal.

The exact strength is clinically important. A tablet containing sildenafil, tadalafil, or both should never be treated as interchangeable with another tablet simply because the products are used for the same condition.

How it affects the body

PDE5 inhibitors prevent the breakdown of cyclic guanosine monophosphate, known as cGMP, in the smooth muscle of the corpus cavernosum. Sexual stimulation releases nitric oxide, which raises cGMP levels and relaxes penile blood vessels. Increased blood flow then supports erection development and maintenance.

Sildenafil Citrate and Tadalafil both inhibit PDE5, yet they differ in pharmacokinetics. Sildenafil generally has a shorter activity window, while tadalafil remains active for longer in standard clinical use. These differences affect timing, interaction risk, and the period during which adverse effects may occur.

The mechanism does not increase sexual desire by itself. It also does not correct every cause of erectile dysfunction. Diabetes, vascular disease, low testosterone, depression, medication effects, relationship difficulties, and neurological disorders can all contribute to erection problems.

Clinical safety information for PDE5 inhibitors from the FDA and Health Canada identifies nitrate-related hypotension as a major concern [1]; guidance from NICE and the MHRA also supports cardiovascular and medicine-interaction review.

Therapeutic indications

Sildalist tablets are intended for erectile dysfunction in adult men. Erectile dysfunction means a repeated inability to achieve or maintain an erection sufficient for satisfactory sexual activity.

Potential clinical benefits of PDE5-inhibitor treatment include:

  • Easier erection development during sexual stimulation.
  • Better erection maintenance for some men.
  • Greater sexual confidence when the underlying cause responds to vasodilator treatment.
  • A treatment option when lifestyle measures alone have not resolved symptoms.

Results vary. A tablet cannot guarantee an erection, and it cannot overcome a complete lack of sexual stimulation.

Common mistakes

Several practical errors can reduce benefit or increase risk:

  • Taking a second tablet because the first dose did not work quickly.
  • Combining Sildalist with another PDE5 inhibitor.
  • Using nitrates after chest pain develops without telling emergency staff about the PDE5 inhibitor.
  • Drinking heavily before sexual activity.
  • Taking the tablet after a very large, fatty meal when a sildenafil component is involved.
  • Splitting a high-strength tablet to guess a lower dose.
  • Ignoring repeated dizziness or near-fainting.
  • Waiting at home with an erection lasting more than four hours.
  • Failing to mention alpha-blockers, amlodipine, warfarin, or antifungal treatment.
  • Assuming that a missed dose should be doubled later.

One overlooked detail concerns emergency care: tell paramedics or emergency-department staff when a PDE5 inhibitor was taken. This information affects the safe use of nitrate medicines during chest-pain treatment.

Reasons not to use it

Sildalist is not suitable for a man who uses organic nitrates for angina or recreational nitrites known as “poppers.” The combination can cause a dangerous fall in blood pressure because both treatments increase vasodilation.

  • Use of nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, or recreational nitrites.
  • Sexual activity advised against because of unstable heart disease.
  • Serious allergic reaction to a PDE5 inhibitor.
  • Previous sudden vision loss attributed to non-arteritic anterior ischemic optic neuropathy.
  • Severe hypotension or uncontrolled hypertension.
  • Concomitant use of another PDE5 inhibitor or erectile-dysfunction medicine.
  • A serious cardiovascular risk that makes sexual activity unsafe.

Other medicines require a specific interaction review:

  • Alpha-blockers: may cause symptomatic hypotension, especially when treatment begins or doses change.
  • Amlodipine and other antihypertensives: can add to blood-pressure lowering.
  • Clarithromycin and ketoconazole: may increase exposure to PDE5-inhibitor substances through CYP3A4 inhibition.
  • Carbamazepine and dexamethasone: may alter drug levels through enzyme induction.
  • Isoniazid: can affect hepatic drug metabolism and requires medication review.
  • Warfarin: needs an individual interaction assessment, especially when bleeding risk or multiple medicines are present.
  • Alcohol: may increase dizziness, fainting, and impaired blood-pressure control.
  • Grapefruit juice: may increase exposure to some medicines metabolised through CYP3A4.

When this is not for you

This medication is not for you if:

  • You use nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, or recreational nitrites.
  • You have been advised to avoid sexual activity because of unstable heart disease.
  • You have had a serious allergic reaction to a PDE5 inhibitor.
  • You have experienced sudden vision loss attributed to non-arteritic anterior ischemic optic neuropathy.
  • You have severe hypotension or uncontrolled hypertension.
  • You are taking another PDE5 inhibitor or erectile-dysfunction medicine.
  • A prescriber has identified a serious cardiovascular risk that makes sexual activity unsafe.

Possible side effects

PDE5-inhibitor side effects can include headache, facial flushing, indigestion, nasal congestion, dizziness, back pain, muscle aches, and changes in vision. The pattern depends on the active substance, strength, dose interval, and individual sensitivity.

Possible symptoms include:

  • Headache or pressure in the head.
  • Warmth or facial redness.
  • Heartburn, dyspepsia, or stomach discomfort.
  • Blocked nose.
  • Light-headedness when standing.
  • Blurred vision or altered colour perception.
  • Palpitations.
  • Back or muscle pain, more often associated with tadalafil treatment.

Combination exposure may increase the chance of dose-related adverse effects. Alcohol can worsen dizziness and blood-pressure reduction.

If dizziness occurs, sit or lie down rather than trying to walk it off. Fainting after a PDE5-inhibitor tablet requires urgent medical assessment.

Urgent symptoms include chest pain, severe breathlessness, fainting, sudden hearing loss, sudden vision loss, an allergic reaction, or an erection lasting longer than four hours. Priapism can damage penile tissue if treatment is delayed.

A practical detail is often missed: visual symptoms after sildenafil may be transient, but sudden loss of vision is not a routine side effect to monitor at home. It requires emergency assessment.

Comparison

Approach Main clinical feature Main limitation
Sildenafil-based treatment Shorter planned-use window for many patients Food and dose-related adverse effects can affect timing
Tadalafil-based treatment Longer activity window in standard treatment The longer exposure may prolong adverse effects
Combination PDE5-inhibitor treatment Exposure to more than one PDE5-inhibitor mechanism Greater complexity and possible additive blood-pressure effects

Sildenafil and tadalafil should not be combined casually. The FDA prescribing information for tadalafil describes prolonged exposure and clinically relevant interactions with nitrates, alpha-blockers, and potent CYP3A4 inhibitors [2].

What doctors say

In clinical practice, doctors usually assess erectile dysfunction as a vascular symptom rather than treating the erection problem in isolation. Recurrent erectile difficulty can occur alongside hypertension, diabetes, obesity, smoking-related vascular disease, sleep disorders, or medication effects.

A prescriber will usually ask about chest pain, exercise tolerance, blood-pressure treatment, nitrate use, previous eye problems, and other erectile-dysfunction medicines. Those questions determine whether sexual activity and PDE5-inhibitor treatment are medically appropriate.

Patients often expect a stronger tablet to produce a stronger result. The more useful clinical goal is the lowest dose that provides an adequate response without troublesome adverse effects. High exposure can make headache or dizziness more likely without correcting an underlying vascular problem.

Tadalafil’s longer duration can suit planned flexibility, while sildenafil’s shorter window may suit men who prefer more defined timing. A combination approach adds complexity and should not be treated as a routine escalation pathway. Shared decision-making should account for cardiovascular risk, interaction potential, and treatment goals.

Comparison

Abhigra

Active ingredient: Sildenafil
100mg
From $ 113.88
pills
3.7 (3)

Avana

Active ingredient: Avanafil
100mg 200mg 50mg
From $ 262.08
pills
3.7 (3)

Cenforce

Active ingredient: Sildenafil
100mg 120mg 130mg 150mg 200mg 25mg 50mg
From $ 81.12
tablets
3.6 (4)

Cenforce Soft

Active ingredient: Sildenafil
100mg
From $ 90.48
pills
3.7 (5)

Confido

Active ingredient: Confido
60caps
From $ 157.56
bottles
3.7 (5)

Comparison table: Erectile Dysfunction

Common questions

What happens after stopping Sildalist, and does it need tapering?

PDE5-inhibitor treatment does not usually require tapering because it does not create the type of physiological dependence associated with some sedative medicines. Erectile difficulties may return when treatment stops because the underlying vascular, hormonal, neurological, or psychological cause remains. Health Canada’s 2023 sildenafil safety information supports using the prescribed dose rather than gradually increasing or reducing it without clinical direction.

How does Sildalist differ from a single PDE5 inhibitor?

A single-agent treatment contains one PDE5-inhibitor substance, such as sildenafil or tadalafil, while a combination approach may expose the body to more than one substance from the same class. The longer activity profile associated with tadalafil differs from the more defined timing commonly associated with sildenafil. The European Medicines Agency product information for tadalafil from 2023 highlights the need to consider duration, cardiovascular status, and medicine interactions when selecting treatment.

How soon should an effect become noticeable?

The response depends on timing, sexual stimulation, food, alcohol, dose, and individual health. Failure to notice an immediate effect does not justify taking another tablet within the same 24-hour period. Clinical prescribing information reviewed by the FDA in 2024 describes PDE5 inhibitors as treatments that support the erectile response during sexual stimulation, not as automatic erection-inducing agents.

How long can a treatment course last, and is long-term use acceptable?

Treatment may be used intermittently or for longer periods when a prescriber reviews cardiovascular health, adverse effects, and ongoing need. Long-term use is not a reason to increase the dose or combine products. A 2023 Health Canada product-monograph framework for sildenafil supports periodic assessment when erectile dysfunction persists, worsens, or appears with new cardiovascular symptoms.

Which condition rules out Sildalist?

Use with organic nitrates is the clearest exclusion because the combination can cause a severe and potentially dangerous fall in blood pressure. Unstable cardiovascular disease may also make sexual activity unsafe, even if the tablet itself is tolerated. The FDA’s 2024 safety information for PDE5-inhibitor treatment identifies nitrate use as a major contraindication.

Can Sildalist be combined with blood-pressure medicines or supplements?

Amlodipine, alpha-blockers, and other antihypertensives may add to blood-pressure reduction and require individual review. Grapefruit products, alcohol, and supplements with blood-pressure-lowering effects may also increase dizziness or fainting risk. The European Medicines Agency product information for tadalafil from 2023 emphasises medication review for vasodilator combinations and potent enzyme inhibitors such as clarithromycin and ketoconazole.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Customer Feedback on Sildalist

3.7
Based on 3 reviews
Richard, 26 Ottawa
Verified
Rating: 4 out of 5

Ottawa, took one prescribed tablet before planned sexual activity on one occasion and noticed a stronger response than before. He also described facial warmth and mild nasal congestion during the first few hours, so he avoided repeating the dose.

Nov 15, 2026
Kevin, 56 Abbotsford Several weeks
Verified
Rating: 3.5 out of 5

Abbotsford, used the prescribed treatment for several weeks and reported better erection maintenance, but dizziness appeared when he combined it with alcohol. His prescriber reviewed his blood-pressure medicines and changed the plan.

Oct 19, 2026
Michael, 51 Winnipeg
Verified
Rating: 3.5 out of 5

Winnipeg, took one prescribed tablet on one occasion and said it helped after an initially disappointing attempt. He had taken it after a heavy meal, and the delayed onset led him to consider another dose; he later learned that repeating it within 24 hours was unsafe.

Nov 1, 2026

Sources

  1. U.S. Food and Drug Administration (2024). Prescribing Information: Viagra (sildenafil citrate).
  2. U.S. Food and Drug Administration (2024). Prescribing Information: Cialis (tadalafil).
Get our free app Shop faster and track your orders 3.8 · 504 reviews Install